{
  "trial_id": "NCT00420433",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Newly diagnosed bone (from calvarium to pelvis include ribs and sternum) and nonosseous metastasis or primary breast tumor",
      "label": "met",
      "evidence": "diagnosis"
    },
    {
      "criterion": "Zubrod performance status 2 or less",
      "label": "met",
      "evidence": "examination"
    },
    {
      "criterion": "Patient must receive systemic treatment (e.g., chemotherapy, hormonal therapy) for this newly diagnosed metastatic disease",
      "label": "met",
      "evidence": "treatment plan"
    },
    {
      "criterion": "Patients must sign an informed consent document indicating awareness that this study is not focusing on the verification of treatment agents but on verification of modalities to assess bone tumor response",
      "label": "met",
      "evidence": "consent document"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients who have less than 3 months interval from completion of treatment (chemotherapy and/or radiation therapy) for primary breast cancer",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "History or presence of brain/leptomeningeal metastasis",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has a confirmed diagnosis of Paget's Disease of Bone and is receiving Bisphosphonate treatment. The patient's sister had the same problems, diagnosed with Paget's disease at age 52.",
  "_meta": {
    "topic_id": "74",
    "trial_id": "NCT00420433",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}